Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • IFNAR
    (2)
TargetMol | Tags By Application
  • ELISA
    (2)
  • Functional assay
    (2)
  • FACS
    (1)
  • FCM
    (1)
TargetMol | Tags By ResearchField
  • Immune System
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

anifrolumab

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
Anifrolumab
MEDI-546, MDX-1333
T774321326232-46-5
Anifrolumab(MEDI-546) is a potent type I interferon (IFN) receptor antagonist, a human monoclonal antibody that targets IFN.Anifrolumab inhibits the activity of type I interferon and is used for the prevention and treatment of systemic lupus erythematosus (SLE).
  • $197
In Stock
Size
QTY
Anti-IFNAR1 Antibody
T9901A-1269
Anti-IFNAR1 Antibody (Anifrolumab) is a humanized IgG1 kappa monoclonal antibody targeting the type I interferon receptor subunit 1 (IFNAR1). This product specifically binds to IFNAR1, blocking the interaction of all type I interferons (including all subtypes of IFN-alpha, IFN-beta, and IFN-omega) with the receptor complex. This inhibition blocks the activation of the downstream JAK/STAT signaling pathway, reduces the expression of interferon-stimulated genes (ISGs), and suppresses type I interferon-mediated immune responses.
    Inquiry